BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 18, 1999
View Archived Issues
Scios signs drug screening and license agreement with Telik
Read More
Ares-Serono signs agreement with PowderJect for drug delivery system
Read More
Apotex extends agreement with Cangene
Read More
Preliminary results of testosterone replacement gel reported
Read More
Allelix clones GLP-2 receptor; advances development of ALX-0600
Read More
Preventive AIDS vaccine trial to begin in Thailand
Read More
Proteomics research grant awarded to Kinetek
Read More
New hemophilia treatment approved by Health Canada
Read More
Dainippon will initiate overseas trials of beta3 agonist
Read More
Yamanouchi, Ono establish codevelopment and marketing agreement for bisphosphonate
Read More
Zarix in-licenses oncology drug from Agouron
Read More
Another European market opens up to desirudin
Read More
Specific inhibitors of MEK for cancer and other proliferative disorders
Read More
New series of anticoagulants for oral administration developed at Lilly
Read More
More from SmithKline Beecham on p38 MAP kinase inhibitors
Read More
Patent covers new ADIR compounds with high affinity for imidazoline receptors
Read More
VUFB's phase III antirheumatic agent is available for licensing
Read More
Roche discloses inhibitors of TNF-alpha/TGF-alpha release, keratinocyte proliferation
Read More
First orally active, nonsteroidal androgen receptor agonist discovered at Ligand
Read More
CD-437, a novel retinoid compound targeted to the treatment of leukemia
Read More
Inhale branches out into pulmonary controlled release
Read More
AZT-cyclam/bicyclam prodrug conjugates designed at INSERM
Read More
Salix negotiates lafutidine license agreement with Fujirebio
Read More
FR-167653 compared to dexamethasone in acute lung inflammation
Read More
Wyeth-Ayerst seeks European approval of Rapamune
Read More
Amlodipine not associated with adverse arrhythmic events in CAD patients
Read More
CoCensys enters research agreements with Senju and Parke-Davis
Read More
Statins may be drugs of choice for adolescents with HeFH
Read More